Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins

Medical Mycology

Volumn 55, Issue 5, 2017, Pages 563-567

  Borman, Andrew M ^a   Szekely, Adrien ^a   Johnson, Elizabeth M ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Candida auris; Clonal strains; Emerging pathogen; Pathogenic yeasts; RDNA sequencing; United Kingdom

Indexed keywords

CANDIDA; CLADISTICS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA STRUCTURE; EAR; FUNGAL CELL CULTURE; GEOGRAPHIC ORIGIN; HOSPITAL; HUMAN; INDIA; JAPAN; KOREA; KUWAIT; MALAYSIA; MULTICENTER STUDY; NONHUMAN; SEQUENCE DATABASE; SOUTH AFRICA; UNITED KINGDOM; CANDIDIASIS; CLASSIFICATION; CROSS INFECTION; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYLOGENY; SEQUENCE ALIGNMENT;

ANTIFUNGAL AGENT; FUNGAL DNA; RIBOSOMAL SPACER DNA; RIBOSOME DNA;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CROSS INFECTION; DNA, FUNGAL; DNA, RIBOSOMAL; DNA, RIBOSOMAL SPACER; HUMANS; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; SEQUENCE ALIGNMENT; UNITED KINGDOM;

EID: 85026229366     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myw147     Document Type: Article

References (23)

1. Satoh K, Makimura K, Hasumi Y et al. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009; 53: 41-44.
2. KimMN, Shin JH, SungHet al. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis. 2009; 48: e57-61.
3. Chowdhary A, Anil Kumar V, Sharma C et al. Multidrugresistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis. 2014; 33: 919-926.
4. Lee WG, Shin JH, Uh Y et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011; 49: 3139-3142.
5. Chowdhary A, Sharma C, Duggal S et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013; 19: 1670-1673.
6. Sarma S, Kumar N, Sharma S et al. Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol. 2013; 31: 90-91.
7. Kumar D, Banerjee T, Pratap CB et al. Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis. J Infect Dev Ctries. 2015; 9: 435-437.
8. Magobo RE, Corcoran C, Seetharam S et al. Candida aurisassociated candidemia, South Africa. Emerg Infect Dis. 2014; 20: 1250-1251.
9. Calvo B, Melo ASA, Perozo-Mena A et al. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 2016; 73: 369-374.
10. Rodero L, Cuenca-Estrella M, Cordoba S et al. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii. J Clin Microbiol. 2002; 40: 2266-2269.
11. Muro MD, Motta FdeA, BurgerMet al. Echinocandin resistance in two Candida haemulonii isolates from pediatric patients. J Clin Microbiol. 2012; 50: 3783-3785.
12. Kathuria S, Singh PK, Sharma C et al. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by vitek 2, CLSI broth microdilution, and etest method. J Clin Microbiol. 2015; 53: 1823-1830.
13. Moran GP, Coleman DC, Sullivan DJ. Comparative genomics and evolution of pathogenicity in human pathogenic fungi. Eukaryot Cell. 2011; 10: 34-42.
14. Borman AM, Szekely A, Linton CJ et al. Epidemiology, antifungal susceptibility and pathogenicity of Candida africana isolates from the United Kingdom. J Clin Microbiol. 2013; 51: 967-972.
15. Borman AM, Szekely A, Johnson EM. Comparative pathogenicity of United Kingdom isolates of the emerging pathogen, Candida auris and other key pathogenic Candida species. mSphere. 2016; 1: e00189-16.
16. Fraser M, Brown Z, Houldsworth M et al. Rapid identification of 6328 isolates of pathogenic yeasts usingMALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database. Med Mycol. 2015; 54: 80-88.
17. Borman AM, Desnos-Ollivier M, Campbell CK et al. Novel taxa associated with human fungal black-grain mycetomas-Emarellia grisea gen nov. et sp. nov. and Emarellia paragrisea sp. nov. J Clin Microbiol. 2016; 54: 1738-1745.
18. Katoh K, Standley DM. MAFFT Multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013; 30: 772-780.
19. Swofford DL. PAUP. Phylogenetic Analysis Using Parsimony (and Other Methods). Version 4. Sunderland, MA: Sinauer Associates. 2003.
20. Sharma C, Kumar N, Pandey R et al.Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation. New Microbes and New Infect. 2016; 13: 77-82.
21. Schelenz S, Hagen F, Rhodes JL et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016; 5: 35. https://dx.doi.org/10.1186%2Fs13756-016-0132-5.
22. Vallabhaneni S, Kallen A, Tsay S et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus-United States, May 2013- August 2016.MMWR Morb Mortal Wkly Rep. 2016; 65: 1234-1237.
23. Lockhart SR, Etienne KA, Vallabhaneni S et al. Simultaneous emergence of multidrug resistant Candida auris on three continents confirmed by whole genome sequencing and epidemiological analyses. 2016. Clin Infect Dis. doi:10.1093/cid/ciw691.